This week, in-PharmaTechnologist brings you its weekly round-up of the latest changes on the pharmaceutical job ladder from Interphex in New York. We present news from exhibitors Aesica and Patheon, as well as AstraZeneca, Array and Elsevier.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Pfizer's announcement of plans to create a new €130m inhaled
medicines unit at its facility in Amboise, France suggests that the
firm is still intent on investing in inhalation technology, despite
its disappointment with Exubera.
Paladin Labs has reached an agreement in principle to acquire the
outstanding shares of BioEnvelop Inc, which develops, manufactures
and markets rapidly dissolving edible films for use as delivery
systems in the pharmaceutical and...
Fresh from Thermo's $10.4bn (€8.3bn) acquisition of the scientific
equipment and instrument specialists, Fisher Scientific posted
strong third quarter results that showed a profit rise of 62 per
cent coupled with an 11 per cent...
Galapagos are to acquire the drug discovery service operations of
Discovery Partners International for $6.4m in a move that cements
Galapagos' BioFocus division as a top three provider in drug
discovery services worldwide.
Alcan has acquired the outstanding minority share of Propack in a
deal that further cements the company's standing in the Chinese
market. The acquisition forms part of a major restructuring
exercise, in which the closure and...
The GEA Group has completed an agreement to acquire Steris's freeze
dryer (lyophiliser) product line, in a deal that aims to strengthen
the group's Process Engineering Division in the Process Engineering
Galapagos has announced that its acquisition of BioFocus' would
accelerate its transition to a fully integrated drug development
biopharmaceutical company after the two companies reached agreement
on the terms of a recommended...
Novartis has announced the formation of a collaboration with Anadys
Pharmaceuticals to develop Hepatitis C (HCV) and hepatitis B (HBV)
therapeutics in a deal worth at least $570 million (€466 million).
German biotech company Evotec OAI posted decreased third quarterly
revenues of €16.1 million, down 26 per cent compared to 2003.
Evotec's performance reflects the difficult operating environment
for companies supplying drug discovery...
Novel approaches to administering drugs took a step forward after
Aradigm announced positive trial results in its Intraject
needle-free delivery system, which paves the way for a viable
alternative to the standard needle injection.
Antibody technology company MorphoSys has formed a marketing
collaboration with Genefrontier, with a view to accessing the
Japanese life science market. This agreement will aim to establish
MorphoSys' HuCAL technology in the...
Two UK packaging machinery engineers, Autowrappers and Europack,
have been bought by Bradman Lake to create a packaging company that
can supply a full range of machinery and compete with the big
players in the pharmaceutical and food...
Pressure on pharma ingredient supplier Lonza has continued into the
first half of the year, with consistently low use of custom
manufacturing capacity and weak demand for biomanufacturing
contributing to a 37 per cent drop in operating...
Tecan second-quarter results reveal some signs of recovery after a
torrid first quarter and the departure of former chief executive
Emile Sutcliffe, with diagnostics holding back an improved
performance in biopharma.